Survivors of childhood Hodgkin lymphoma face high long-term risk of solid cancers
New research refines existing evidence that survivors of childhood Hodgkin lymphoma face an elevated risk…
Browsing: Lymphoma
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
ASH 2018: More than half of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma in ZUMA-1 trial
A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large…
ASH 2018: New research on stem cell transplantation for myeloid cancers
Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation was the focus…
One test to diagnose them all: researchers exploit cancers’ unique DNA signature
Abu Sina, The University of Queensland; Laura G. Carrascosa, The University of Queensland, and Matt…
First of its kind research models immune responses in cellular immunotherapies
In the Cellular Immunotherapy and Transplantation Program at Virginia Commonwealth University Massey Cancer Center, scientists…
ESMO 2018: Barriers to early clinical trial access for adolescents and young adults still exist, study shows
Young cancer patients at the crossroads of childhood and adulthood seem to be stuck in…
Stop worrying and trust the evidence: it’s very unlikely Roundup causes cancer
Ian Musgrave, University of Adelaide The common weed killer Roundup (glyphosate) is back in the…
FDA approves duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
The Food and Drug Administration has granted regular approval to duvelisib for adult patients with relapsed…
Blood cancer patients benefit from breakthrough genetic testing service
Cutting-edge DNA sequencing technology has been used by QUT researchers at the new Australian Translational…